Editorial
Biomarkers of preclinical ventricular dysfunction in type 2 diabetes mellitus
Biomarcadores de disfunción ventricular preclínica en la diabetes mellitus tipo 2
a Institut de Cor, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
b Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
c Hospital Clínico Universitario Valencia, INCLIVA, Valencia, Spain
d Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain
e Servicio de Cardiología, Complejo Hospitalario de Toledo, Toledo, Spain
Read
1251
Timeswas read the article
304
Total PDF
947
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 September | 47 | 17 | 64 |
| 2023 August | 41 | 14 | 55 |
| 2023 July | 74 | 34 | 108 |
| 2023 June | 81 | 30 | 111 |
| 2023 May | 95 | 40 | 135 |
| 2023 April | 78 | 21 | 99 |
| 2023 March | 122 | 28 | 150 |
| 2023 February | 92 | 28 | 120 |
| 2023 January | 193 | 48 | 241 |
| 2022 December | 79 | 17 | 96 |
| 2022 November | 1 | 0 | 1 |
| 2022 October | 0 | 1 | 1 |
| 2022 September | 4 | 6 | 10 |
| 2022 August | 38 | 16 | 54 |
| 2022 July | 2 | 4 | 6 |
Show all
